{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:59:25Z","timestamp":1791219565691,"version":"4.1.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s40266-018-0534-6","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:41:44Z","timestamp":1521074504000},"page":"275-287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["IgG4-Related Disease: Beyond Glucocorticoids"],"prefix":"10.1007","volume":"35","author":[{"given":"Mitsuhiro","family":"Akiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"534_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539\u201351.","journal-title":"N Engl J Med"},{"key":"534_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/MPA.0000000000000325","volume":"44","author":"A Kanno","year":"2015","unstructured":"Kanno A, Masamune A, Okazaki K, Kamisawa T, Kawa S, Nishimori I, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011. Pancreas. 2015;44:535\u20139.","journal-title":"Pancreas"},{"key":"534_CR3","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1097\/PAS.0b013e3181f7266b","volume":"34","author":"Y Zen","year":"2010","unstructured":"Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34:1812\u20139.","journal-title":"Am J Surg Pathol"},{"key":"534_CR4","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/gast.2002.33022","volume":"122","author":"S Kawa","year":"2002","unstructured":"Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology. 2002;122:1264\u20139.","journal-title":"Gastroenterology"},{"key":"534_CR5","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1136\/gut.2006.095059","volume":"55","author":"T Umemura","year":"2006","unstructured":"Umemura T, Ota M, Hamano H, Katsuyama Y, Kiyosawa K, Kawa S. Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients. Gut. 2006;55:1367\u20138.","journal-title":"Gut"},{"key":"534_CR6","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1572-0241.2007.01750.x","volume":"103","author":"T Umemura","year":"2008","unstructured":"Umemura T, Ota M, Hamano H, Katsuyama Y, Muraki T, Arakura N, et al. Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol. 2008;103:588\u201394.","journal-title":"Am J Gastroenterol"},{"key":"534_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1155\/2011\/264747","volume":"31","author":"M Ota","year":"2011","unstructured":"Ota M, Ito T, Umemura T, Katsuyama Y, Yoshizawa K, Hamano H, et al. Polymorphism in the KCNA3 gene is associated with susceptibility to autoimmune pancreatitis in the Japanese population. Dis Markers. 2011;31:223\u20139.","journal-title":"Dis Markers"},{"key":"534_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/annrheumdis-2016-eular.3046","volume":"75","author":"C Terao","year":"2016","unstructured":"Terao C, Ota M, Shiokawa M, Kuriyama K, Kodama Y, Uchida K, et al. OP0238 Fcgr2b and multiple HLA loci are associated with susceptibility to IGG4-related disease. Ann Rheum Dis. 2016;75:148.","journal-title":"Ann Rheum Dis"},{"key":"534_CR9","doi-asserted-by":"publisher","first-page":"6126707","DOI":"10.1155\/2017\/6126707","volume":"2017","author":"M Buechter","year":"2017","unstructured":"Buechter M, Manka P, Heinemann FM, Lindemann M, Juntermanns B, Canbay A, et al. Outcome and genetic factors in IgG4-associated autoimmune pancreatitis and cholangitis: a single center experience. Gastroenterol Res Pract. 2017;2017:6126707.","journal-title":"Gastroenterol Res Pract"},{"key":"534_CR10","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/art.39773","volume":"68","author":"ZS Wallace","year":"2016","unstructured":"Wallace ZS, Wallace CJ, Lu N, Choi HK, Stone JH. Association of IgG4-related disease with history of malignancy. Arthritis Rheumatol. 2016;68:2283\u20139.","journal-title":"Arthritis Rheumatol"},{"key":"534_CR11","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/hep.26999","volume":"60","author":"LJ Buy Wenniger de","year":"2014","unstructured":"de Buy Wenniger LJ, Culver EL, Beuers U. Exposure to occupational antigens might predispose to IgG4-related disease. Hepatology. 2014;60:1453\u20134.","journal-title":"Hepatology"},{"key":"534_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7326\/M13-2648","volume":"161","author":"M Goldoni","year":"2014","unstructured":"Goldoni M, Bonini S, Urban ML, Palmisano A, De Palma G, Galletti E, et al. Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case\u2013control study. Ann Intern Med. 2014;161:181\u20138.","journal-title":"Ann Intern Med"},{"key":"534_CR13","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1136\/annrheumdis-2014-206405","volume":"74","author":"EL Culver","year":"2015","unstructured":"Culver EL, Vermeulen E, Makuch M, van Leeuwen A, Sadler R, Cargill T, et al. Increased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related disease. Ann Rheum Dis. 2015;74:944\u20137.","journal-title":"Ann Rheum Dis"},{"key":"534_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314548","author":"LM Hubers","year":"2017","unstructured":"Hubers LM, Vos H, Schuurman AR, et al. Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease. Gut. 2017. https:\/\/doi.org\/10.1136\/gutjnl-2017-314548 .","journal-title":"Gut"},{"key":"534_CR15","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1126\/science.1144603","volume":"317","author":"Kolfschoten M Neut van der","year":"2007","unstructured":"van der Neut Kolfschoten M, Schuurman J, Losen M, Bleeker WK, Mart\u00ednez-Mart\u00ednez P, Vermeulen E, et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science. 2007;317:1554\u20137.","journal-title":"Science"},{"key":"534_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.07.038","author":"DC Trampert","year":"2017","unstructured":"Trampert DC, Hubers LM, van de Graaf SFJ, Beuers U. On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease. Biochim Biophys Acta. 2017. https:\/\/doi.org\/10.1016\/j.bbadis.2017.07.038 .","journal-title":"Biochim Biophys Acta."},{"key":"534_CR17","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1136\/gutjnl-2015-310336","volume":"65","author":"M Shiokawa","year":"2016","unstructured":"Shiokawa M, Kodama Y, Kuriyama K, Yoshimura K, Tomono T, Morita T, et al. Pathogenicity of IgG in patients with IgG4-related disease. Gut. 2016;65:1322\u201332.","journal-title":"Gut"},{"key":"534_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00535-014-0977-4","volume":"50","author":"Y Fukui","year":"2015","unstructured":"Fukui Y, Uchida K, Sakaguchi Y, Fukui T, Nishio A, Shikata N, et al. Possible involvement of Toll-like receptor 7 in the development of type 1 autoimmune pancreatitis. J Gastroenterol. 2015;50:435\u201344.","journal-title":"J Gastroenterol"},{"key":"534_CR19","doi-asserted-by":"publisher","first-page":"e2853","DOI":"10.1097\/MD.0000000000002853","volume":"95","author":"M Ohta","year":"2016","unstructured":"Ohta M, Moriyama M, Maehara T, Gion Y, Furukawa S, Tanaka A, et al. DNA microarray analysis of submandibular glands in IgG4-related disease indicates a role for MARCO and other innate immune-related proteins. Medicine (Baltimore). 2016;95:e2853.","journal-title":"Medicine (Baltimore)"},{"key":"534_CR20","doi-asserted-by":"publisher","first-page":"42413","DOI":"10.1038\/srep42413","volume":"7","author":"S Furukawa","year":"2017","unstructured":"Furukawa S, Moriyama M, Miyake K, Nakashima H, Tanaka A, Maehara T, et al. Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease. Sci Rep. 2017;7:42413.","journal-title":"Sci Rep"},{"key":"534_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clim.2014.10.008","volume":"156","author":"S Furukawa","year":"2015","unstructured":"Furukawa S, Moriyama M, Tanaka A, Maehara T, Tsuboi H, Iizuka M, et al. Preferential M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz\u2019s disease. Clin Immunol. 2015;156:9\u201318.","journal-title":"Clin Immunol"},{"key":"534_CR22","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1002\/art.38748","volume":"66","author":"H Tsuboi","year":"2014","unstructured":"Tsuboi H, Nakai Y, Iizuka M, Asashima H, Hagiya C, Tsuzuki S, et al. DNA microarray analysis of labial salivary glands in IgG4-related disease: comparison with Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 2014;66:2892\u20139.","journal-title":"Arthritis Rheumatol"},{"key":"534_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212110","author":"M Akiyama","year":"2017","unstructured":"Akiyama M, Yasuoka H, Yoshimoto K, Takeuchi T. CC-chemokine ligand 18 is a useful biomarker associated with disease activity in IgG4-related disease. Ann Rheum Dis. 2017. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212110 .","journal-title":"Ann Rheum Dis."},{"key":"534_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/art.33320","volume":"64","author":"A Tanaka","year":"2012","unstructured":"Tanaka A, Moriyama M, Nakashima H, Miyake K, Hayashida JN, Maehara T, et al. Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease. Arthritis Rheum. 2012;64:254\u201363.","journal-title":"Arthritis Rheum"},{"key":"534_CR25","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/1756-185X.12725","volume":"19","author":"M Akiyama","year":"2016","unstructured":"Akiyama M, Suzuki K, Kassai Y, Miyazaki T, Morita R, Yoshimura A, et al. Resolution of elevated circulating regulatory T cells by corticosteroids in patients with IgG4-related dacryoadenitis and sialoadenitis. Int J Rheum Dis. 2016;19:430\u20132.","journal-title":"Int J Rheum Dis"},{"key":"534_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.11.017","author":"M Akiyama","year":"2018","unstructured":"Akiyama M. The call for considering follicular helper T cells in IgG4-related disease. J Allergy Clin Immunol. 2018. https:\/\/doi.org\/10.1016\/j.jaci.2017.11.017 .","journal-title":"J Allergy Clin Immunol"},{"key":"534_CR27","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/rheumatology\/kex171","volume":"57","author":"M Akiyama","year":"2018","unstructured":"Akiyama M, Suzuki K, Yasuoka H, Kaneko Y, Yamaoka K, Takeuchi T. Follicular helper T cells in the pathogenesis of IgG4-related disease. Rheumatology (Oxford). 2018;57:236\u201345.","journal-title":"Rheumatology (Oxford)"},{"key":"534_CR28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jaci.2014.03.034","volume":"134","author":"H Mattoo","year":"2014","unstructured":"Mattoo H, Mahajan VS, Della-Torre E, Sekigami Y, Carruthers M, Wallace ZS, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014;134:679\u201387.","journal-title":"J Allergy Clin Immunol"},{"key":"534_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/hep.28568","volume":"64","author":"ME Doorenspleet","year":"2016","unstructured":"Doorenspleet ME, Hubers LM, Culver EL, de Buy Maillette, Wenniger LJ, Klarenbeek PL, Chapman RW, et al. Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary\/pancreatic malignancies. Hepatology. 2016;64:501\u20137.","journal-title":"Hepatology"},{"key":"534_CR30","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/art.39209","volume":"67","author":"M Akiyama","year":"2015","unstructured":"Akiyama M, Suzuki K, Yamaoka K, Yasuoka H, Takeshita M, Kaneko Y, et al. Number of circulating follicular helper 2 T cells correlates with IgG4 and interleukin-4 levels and plasmablast numbers in IgG4-related disease. Arthritis Rheumatol. 2015;67:2476\u201381.","journal-title":"Arthritis Rheumatol"},{"key":"534_CR31","first-page":"949","volume":"33","author":"M Akiyama","year":"2015","unstructured":"Akiyama M, Kaneko Y, Yamaoka K, Hayashi Y, Yasuoka H, Suzuki K, et al. Subclinical labial salivary gland involvement in IgG4-related disease affected with vital organs. Clin Exp Rheumatol. 2015;33:949\u201350.","journal-title":"Clin Exp Rheumatol"},{"key":"534_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13075-016-1064-4","volume":"18","author":"M Akiyama","year":"2016","unstructured":"Akiyama M, Yasuoka H, Yamaoka K, Suzuki K, Kaneko Y, Kondo H, et al. Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease. Arthritis Res Ther. 2016;18:167.","journal-title":"Arthritis Res Ther"},{"key":"534_CR33","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1136\/annrheumdis-2012-201477","volume":"71","author":"T Maehara","year":"2012","unstructured":"Maehara T, Moriyama M, Nakashima H, Miyake K, Hayashida JN, Tanaka A, et al. Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz\u2019s disease. Ann Rheum Dis. 2012;71:2011\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 2","key":"534_CR34","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/annrheumdis-2017-eular.3040","volume":"76","author":"M Akiyama","year":"2017","unstructured":"Akiyama M, Yasuoka H, Yoshimoto K, Takeuchi T. FRI0361 Interleukin-4 induces class-switching to IGG4 and synergistically contributes to plasmablasts differentiation with interleukin-21 through CD40 dependent manner in IGG4-related disease. Ann Rheum Dis. 2017;76(Suppl. 2):623. https:\/\/doi.org\/10.1136\/annrheumdis-2017-eular.3040 .","journal-title":"Ann Rheum Dis."},{"key":"534_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fimmu.2017.00235","volume":"8","author":"A Grados","year":"2017","unstructured":"Grados A, Ebbo M, Piperoglou C, Groh M, Regent A, Samson M, et al. T cell polarization toward TH2\/TFH2 and TH17\/TFH17 in patients with IgG4-related disease. Front Immunol. 2017;8:235.","journal-title":"Front Immunol"},{"key":"534_CR36","doi-asserted-by":"publisher","first-page":"e3970","DOI":"10.1097\/MD.0000000000003970","volume":"95","author":"M Akiyama","year":"2016","unstructured":"Akiyama M, Kaneko Y, Hayashi Y, Takeuchi T. IgG4-related disease involving vital organs diagnosed with lip biopsy: a case report and literature review. Medicine (Baltimore). 2016;95:e3970.","journal-title":"Medicine (Baltimore)"},{"key":"534_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00277-015-2500-2","volume":"95","author":"H Yajima","year":"2016","unstructured":"Yajima H, Yamamoto M, Shimizu Y, Sakurai N, Suzuki C, Naishiro Y, et al. Loss of interleukin-21 leads to atrophic germinal centers in multicentric Castleman\u2019s disease. Ann Hematol. 2016;95:35\u201340.","journal-title":"Ann Hematol"},{"key":"534_CR38","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.4049\/jimmunol.1601507","volume":"199","author":"R Kamekura","year":"2017","unstructured":"Kamekura R, Takano K, Yamamoto M, Kawata K, Shigehara K, Jitsukawa S, et al. Cutting edge: a critical role of lesional T follicular helper cells in the pathogenesis of IgG4-related disease. J Immunol. 2017;199:2624\u20139.","journal-title":"J Immunol"},{"key":"534_CR39","doi-asserted-by":"publisher","first-page":"9512","DOI":"10.3892\/mmr.2017.7780","volume":"16","author":"H Yang","year":"2017","unstructured":"Yang H, Wei R, Liu Q, Shi Y, Li J. Frequency and distribution of CD4+CXCR5+ follicular B helper T cells within involved tissues in IgG4-related ophthalmic disease. Mol Med Rep. 2017;16:9512\u201320.","journal-title":"Mol Med Rep"},{"key":"534_CR40","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2177\/jsci.40.206","volume":"40","author":"T Maehara","year":"2017","unstructured":"Maehara T. IgG4-related disease: mechanistic insights from both clinical and immunologic understanding of this condition. Nihon Rinsho Meneki Gakkai Kaishi. 2017;40:206\u201312.","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"issue":"3","key":"534_CR41","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/rheumatology\/kex455","volume":"57","author":"S Kubo","year":"2018","unstructured":"Kubo S, Nakayamada S, Zhao J, Yoshikawa M, Miyazaki Y, Nawata A, et al. Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease. Rheumatology (Oxford). 2018;57(3):514\u201324.","journal-title":"Rheumatology (Oxford)"},{"key":"534_CR42","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","volume":"138","author":"H Mattoo","year":"2016","unstructured":"Mattoo H, Mahajan VS, Maehara T, Deshpande V, Della-Torre E, Wallace ZS, et al. Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol. 2016;138:825\u201338.","journal-title":"J Allergy Clin Immunol"},{"key":"534_CR43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/rheumatology\/kes358","volume":"52","author":"Y Shimizu","year":"2013","unstructured":"Shimizu Y, Yamamoto M, Naishiro Y, Sudoh G, Ishigami K, Yajima H, et al. Necessity of early intervention for IgG4-related disease\u2013delayed treatment induces fibrosis progression. Rheumatology (Oxford). 2013;52:679\u201383.","journal-title":"Rheumatology (Oxford)"},{"key":"534_CR44","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","volume":"74","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Mattoo H, Carruthers M, Mahajan VS, Della Torre E, Lee H, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74:190\u20135.","journal-title":"Ann Rheum Dis"},{"key":"534_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13075-017-1231-2","volume":"19","author":"W Lin","year":"2017","unstructured":"Lin W, Zhang P, Chen H, Chen Y, Yang H, Zheng W, et al. Circulating plasmablasts\/plasma cells: a potential biomarker for IgG4-related disease. Arthritis Res Ther. 2017;19:25.","journal-title":"Arthritis Res Ther"},{"key":"534_CR46","unstructured":"Akiyama M, Sasaki T, Kaneko Y, Yasuoka H, Suzuki K, Yamaoka K, Takeuchi T. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sj\u00f6gren\u2019s syndrome adults from a defined population. Clin Exp Rheumatol. 2018 (Epub ahead of print])"},{"key":"534_CR47","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ki.2010.271","volume":"78","author":"T Saeki","year":"2010","unstructured":"Saeki T, Nishi S, Imai N, Ito T, Yamazaki H, Kawano M, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010;78:1016\u201323.","journal-title":"Kidney Int"},{"key":"534_CR48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3109\/14397595.2014.990674","volume":"25","author":"Y Nakatsuka","year":"2015","unstructured":"Nakatsuka Y, Handa T, Nakamoto Y, Nobashi T, Yoshihuji H, Tanizawa K, et al. Total lesion glycolysis as an IgG4-related disease activity marker. Mod Rheumatol. 2015;25:579\u201384.","journal-title":"Mod Rheumatol"},{"key":"534_CR49","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/acr.22058","volume":"66","author":"M Ebbo","year":"2014","unstructured":"Ebbo M, Grados A, Guedj E, Gobert D, Colavolpe C, Zaidan M, et al. Usefulness of 2-[18F]-fluoro-2-deoxy-d-glucose-positron emission tomography\/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care Res. 2014;66:86\u201396.","journal-title":"Arthritis Care Res"},{"key":"534_CR50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21\u201330.","journal-title":"Mod Rheumatol"},{"key":"534_CR51","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1136\/annrheumdis-2017-211330","volume":"76","author":"H Umehara","year":"2017","unstructured":"Umehara H, Okazaki K, Kawano M, Mimori T, Chiba T. How to diagnose IgG4-related disease. Ann Rheum Dis. 2017;76:e46.","journal-title":"Ann Rheum Dis"},{"key":"534_CR52","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/14397595.2017.1290911","volume":"27","author":"H Umehara","year":"2017","unstructured":"Umehara H, Okazaki K, Nakamura T, Satoh-Nakamura T, Nakajima A, Kawano M, et al. Current approach to the diagnosis of IgG4-related disease: combination of comprehensive diagnostic and organ-specific criteria. Mod Rheumatol. 2017;27:381\u201391.","journal-title":"Mod Rheumatol"},{"key":"534_CR53","doi-asserted-by":"publisher","first-page":"e8710","DOI":"10.1097\/MD.0000000000008710","volume":"96","author":"R Anan","year":"2017","unstructured":"Anan R, Akiyama M, Kaneko Y, Kikuchi J, Suzuki K, Matsubara S, et al. Polymyositis with elevated serum IgG4 levels and abundant IgG4+ plasma cell infiltration: a case report and literature review. Medicine. 2017;96:e8710.","journal-title":"Medicine"},{"key":"534_CR54","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1016\/j.humpath.2013.05.023","volume":"44","author":"SY Chang","year":"2013","unstructured":"Chang SY, Keogh KA, Lewis JE, Ryu JH, Cornell LD, Garrity JA, et al. IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener\u2019s): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases. Hum Pathol. 2013;44:2432\u20137.","journal-title":"Hum Pathol"},{"key":"534_CR55","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.autrev.2017.07.020","volume":"16","author":"FX Danlos","year":"2017","unstructured":"Danlos FX, Rossi GM, Blockmans D, Emmi G, Kronbichler A, Durupt S, et al. Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome. Autoimmun Rev. 2017;16:1036\u201343.","journal-title":"Autoimmun Rev"},{"key":"534_CR56","doi-asserted-by":"publisher","first-page":"e000432","DOI":"10.1136\/rmdopen-2017-000432","volume":"3","author":"T Sasaki","year":"2017","unstructured":"Sasaki T, Akiyama M, Kaneko Y, Mori T, Yasuoka H, Suzuki K, et al. Distinct features distinguishing IgG4-related disease from multicentric Castleman\u2019s disease. RMD Open. 2017;3:e000432.","journal-title":"RMD Open"},{"key":"534_CR57","first-page":"392","volume":"29","author":"C Roux-Serratrice de","year":"2002","unstructured":"de Roux-Serratrice C, Serratrice J, Granel B, Disdier P, Bartoli JM, Pache X, et al. Periaortitis heralding Wegener\u2019s granulomatosis. J Rheumatol. 2002;29:392\u20134.","journal-title":"J Rheumatol"},{"issue":"Suppl. 1","key":"534_CR58","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1016\/S0167-5273(00)00176-5","volume":"75","author":"K Nakabayashi","year":"2000","unstructured":"Nakabayashi K, Kamiya Y, Nagasawa T. Aortitis syndrome associated with positive perinuclear antineutrophil cytoplasmic antibody: report of three cases. Int J Cardiol. 2000;75(Suppl. 1):S89\u201394.","journal-title":"Int J Cardiol"},{"key":"534_CR59","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s100670050038","volume":"19","author":"D Blockmans","year":"2000","unstructured":"Blockmans D, Baeyens H, Van Loon R, Lauwers G, Bobbaers H. Periaortitis and aortic dissection due to Wegener\u2019s granulomatosis. Clin Rheumatol. 2000;19:161\u20134.","journal-title":"Clin Rheumatol"},{"issue":"1 Suppl. 64","key":"534_CR60","first-page":"S35","volume":"29","author":"WR Bijlsma","year":"2011","unstructured":"Bijlsma WR, Hen\u00e9 RJ, Mourits MP, Kalmann R. Orbital mass as manifestation of Wegener\u2019s granulomatosis: an ophthalmologic diagnostic approach. Clin Exp Rheumatol. 2011;29(1 Suppl. 64):S35\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"534_CR61","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","volume":"106","author":"N Nishimoto","year":"2005","unstructured":"Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, Nakano S, et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood. 2005;106:2627\u201332.","journal-title":"Blood"},{"key":"534_CR62","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s00277-017-3111-x","volume":"96","author":"M Akiyama","year":"2017","unstructured":"Akiyama M, Yasuoka H, Takeuchi T. Interleukin-6 in idiopathic multicentric Castleman\u2019s disease after long-term tocilizumab. Ann Hematol. 2017;96:2117\u20139.","journal-title":"Ann Hematol"},{"key":"534_CR63","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39132","volume":"67","author":"A Khosroshahi","year":"2015","unstructured":"Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67:1688\u201399.","journal-title":"Arthritis Rheumatol"},{"key":"534_CR64","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/14397595.2016.1259602","volume":"27","author":"Y Masaki","year":"2017","unstructured":"Masaki Y, Matsui S, Saeki T, Tsuboi H, Hirata S, Izumi Y, et al. A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease. Mod Rheumatol. 2017;27:849\u201354.","journal-title":"Mod Rheumatol"},{"key":"534_CR65","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/1756-185X.13088","volume":"20","author":"Q Wu","year":"2017","unstructured":"Wu Q, Chang J, Chen H, Chen Y, Yang H, Fei Y, et al. Efficacy between high and medium doses of glucocorticoid therapy in remission induction of IgG4-related diseases: a preliminary randomized controlled trial. Int J Rheum Dis. 2017;20:639\u201346.","journal-title":"Int J Rheum Dis"},{"key":"534_CR66","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/gutjnl-2016-312049","volume":"66","author":"A Masamune","year":"2017","unstructured":"Masamune A, Nishimori I, Kikuta K, Tsuji I, Mizuno N, Iiyama T, et al. Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut. 2017;66:487\u201394.","journal-title":"Gut"},{"key":"534_CR67","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3109\/14397595.2014.950036","volume":"25","author":"M Yamamoto","year":"2015","unstructured":"Yamamoto M, Yajima H, Takahashi H, Yokoyama Y, Ishigami K, Shimizu Y, et al. Everyday clinical practice in IgG4-related dacryoadenitis and\/or sialadenitis: results from the SMART database. Mod Rheumatol. 2015;25:199\u2013204.","journal-title":"Mod Rheumatol"},{"key":"534_CR68","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.1038\/s41598-017-06520-5","volume":"7","author":"F Yunyun","year":"2017","unstructured":"Yunyun F, Yu C, Panpan Z, Hua C, Di W, Lidan Z, et al. Efficacy of cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids. Sci Rep. 2017;7:6195.","journal-title":"Sci Rep"},{"key":"534_CR69","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1093\/rheumatology\/kev244","volume":"54","author":"E Della-Torre","year":"2015","unstructured":"Della-Torre E, Campochiaro C, Bozzolo EP, Dagna L, Scotti R, Nicoletti R, et al. Methotrexate for maintenance of remission in IgG4-related disease. Rheumatology (Oxford). 2015;54:1934\u20136.","journal-title":"Rheumatology (Oxford)"},{"key":"534_CR70","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/imj.13430","volume":"47","author":"Y Wang","year":"2017","unstructured":"Wang Y, Li K, Gao D, Luo G, Zhao Y, Wang X, et al. Combination therapy of leflunomide and glucocorticoids for the maintenance of remission in patients with IgG4-related disease: a retrospective study and literature review. Intern Med J. 2017;47:680\u20139.","journal-title":"Intern Med J"},{"key":"534_CR71","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/gutjnl-2012-302886","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebig RR, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013;62:1607\u201315.","journal-title":"Gut"},{"key":"534_CR72","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1055\/s-0034-1366331","volume":"52","author":"M Buechter","year":"2014","unstructured":"Buechter M, Klein CG, Kloeters C, Schlaak JF, Canbay A, Gerken G, et al. Tacrolimus as a reasonable alternative in a patient with steroid-dependent and thiopurine-refractory autoimmune pancreatitis with IgG4-associated cholangitis. Z Gastroenterol. 2014;52:564\u20138.","journal-title":"Z Gastroenterol"},{"key":"534_CR73","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015;74:1171\u20137.","journal-title":"Ann Rheum Dis"},{"key":"534_CR74","doi-asserted-by":"publisher","first-page":"e0183844","DOI":"10.1371\/journal.pone.0183844","volume":"12","author":"M Ebbo","year":"2017","unstructured":"Ebbo M, Grados A, Samson M, Groh M, Loundou A, Rigolet A, et al. Long-term efficacy and safety of rituximab in IgG4-related disease: data from a French nationwide study of thirty-three patients. PLoS One. 2017;12:e0183844.","journal-title":"PLoS One"},{"key":"534_CR75","doi-asserted-by":"crossref","unstructured":"Stone JH, Wallace ZS, Perugino CA, Fernandes AD, Patel P, Foster PA, Zack DJ. Final results of an open label phase 2 study of a reversible B cell inhibitor, Xmab\u00ae5871, in IgG4-related disease [abstract]. Arthritis Rheumatol. 2017;69(Suppl. 10).","DOI":"10.1136\/annrheumdis-2017-eular.3301"},{"key":"534_CR76","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1136\/annrheumdis-2016-210400","volume":"75","author":"G Carvajal Alegria","year":"2016","unstructured":"Carvajal Alegria G, Pochard P, Pers JO, Cornec D. Could abatacept directly target expanded plasmablasts in IgG4-related disease? Ann Rheum Dis. 2016;75:e73.","journal-title":"Ann Rheum Dis"},{"key":"534_CR77","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1136\/annrheumdis-2016-209368","volume":"75","author":"M Yamamoto","year":"2016","unstructured":"Yamamoto M, Takahashi H, Takano K, Shimizu Y, Sakurai N, Suzuki C, et al. Efficacy of abatacept for IgG4-related disease over 8 months. Ann Rheum Dis. 2016;75:1576\u20138.","journal-title":"Ann Rheum Dis"},{"key":"534_CR78","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1136\/annrheumdis-2016-209718","volume":"76","author":"T Sasaki","year":"2017","unstructured":"Sasaki T, Akiyama M, Kaneko Y, et al. Risk factors for disease relapse in IGG4-related disease following glucocorticoids treatment. Ann Rheum Dis. 2017;76:712\u20133.","journal-title":"Ann Rheum Dis"},{"key":"534_CR79","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/art.39773","volume":"68","author":"ZS Wallace","year":"2016","unstructured":"Wallace ZS, Wallace CJ, Lu N, Choi HK, Stone JH. Association of IgG4-related disease with history of malignancy. Arthritis Rheumatol. 2016;68:2283\u20139.","journal-title":"Arthritis Rheumatol"},{"key":"534_CR80","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3899\/jrheum.150436","volume":"42","author":"J Asano","year":"2015","unstructured":"Asano J, Watanabe T, Oguchi T, Kanai K, Maruyama M, Ito T, et al. Association between immunoglobulin G4-related disease and malignancy within 12\u00a0years after diagnosis: an analysis after longterm followup. J Rheumatol. 2015;42:2135\u201342.","journal-title":"J Rheumatol"},{"key":"534_CR81","doi-asserted-by":"crossref","unstructured":"Nishida K, Sogabe Y, Makihara A, Senoo A, Morimoto H, Takeuchi M, et al. Ocular adnexal marginal zone lymphoma arising in a patient with IgG4-related ophthalmic disease. Mod Rheumatol. 2016 (Epub ahead of print).","DOI":"10.1080\/14397595.2016.1216733"},{"key":"534_CR82","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/PAS.0b013e31816148ad","volume":"32","author":"W Cheuk","year":"2008","unstructured":"Cheuk W, Yuen HK, Chan AC, Shih LY, Kuo TT, Ma MW, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32:1159\u201367.","journal-title":"Am J Surg Pathol"},{"key":"534_CR83","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.jvs.2017.08.073","volume":"66","author":"M Akiyama","year":"2017","unstructured":"Akiyama M. Regarding, \u201cUpregulated interleukins (IL-6, IL-10, and IL-13) in immunoglobulin G4-related aortic aneurysm patients\u201d. J Vasc Surg. 2017;66:1919.","journal-title":"J Vasc Surg"},{"key":"534_CR84","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1056\/NEJMc1711031","volume":"377","author":"M Akiyama","year":"2017","unstructured":"Akiyama M. Trial of tocilizumab in giant-cell arteritis. N Engl J Med. 2017;377:1493\u20134.","journal-title":"N Engl J Med"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-018-0534-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-018-0534-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-018-0534-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T18:10:59Z","timestamp":1570903859000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-018-0534-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":84,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["534"],"URL":"https:\/\/doi.org\/10.1007\/s40266-018-0534-6","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]},"assertion":[{"value":"15 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No funding was received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Mitsuhiro Akiyama has received consulting fees, speaking fees, and honoraria from Asahi Kasei Co., Cure Grades Co., and Eisai Co., Ltd, and a research grant from Mitsubishi Tanabe Pharma Co and Keio Medical Association. Tsutomu Takeuchi has received consulting fees, speaking fees and\/or honoraria from Pfizer Japan, Mitsubishi Tanabe Pharma, Eisai, Astellas Pharma, and UCB (less than $10,000 each) and Chugai Pharmaceutical, Bristol-Myers K.K., Daiichi Sankyo, AbbVie, Janssen Pharmaceutical K.K., Pfizer Japan, Asahi Kasei Pharma, Takeda Pharmaceutical, AstraZeneca K.K., Eli Lilly Japan K.K., and Novartis Pharma K.K. (more than $10,000 each).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}